| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9c55cbd632f124625c19c848aaffd9c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4846 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 |
| filingDate |
2013-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b592dedde44845716f0d316a48722a6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b009a7913d865127df6645d94171ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b7193c240d2880e6e08e49191681718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f8d9e622640b65c3611510fd7fd733c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74298f282c6cd2f70418af2baf59d407 |
| publicationDate |
2013-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013185114-A2 |
| titleOfInvention |
Chimeric clotting factors |
| abstract |
The invention provides chimeric clotting factors comprising an activatable clotting factor and an enhancer moiety. The activatable clotting factor allows the chimeric clotting factor to be activated at the site of coagulation. The enhancer moiety can additionally improve procoagulation activities of the chimeric clotting factors. The chimeric clotting factors can further be improved by fusion to a half-life extender, which improves a pharmacokinetics property of the chimeric clotting factor. The invention also includes methods of making and methods of using these chimeric clotting factors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11123438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11168316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10202595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3527218-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11261437-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9486507-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2717898-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2717898-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016150449-A1 |
| priorityDate |
2012-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |